GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Jean Coutu Group (PJC) Inc (OTCPK:JCOUF) » Definitions » EV-to-EBIT

The Jean Coutu Group (PJC) (The Jean Coutu Group (PJC)) EV-to-EBIT : 18.16 (As of May. 10, 2024)


View and export this data going back to . Start your Free Trial

What is The Jean Coutu Group (PJC) EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, The Jean Coutu Group (PJC)'s Enterprise Value is $3,499 Mil. The Jean Coutu Group (PJC)'s EBIT for the trailing twelve months (TTM) ended in Nov. 2017 was $193 Mil. Therefore, The Jean Coutu Group (PJC)'s EV-to-EBIT for today is 18.16.

The historical rank and industry rank for The Jean Coutu Group (PJC)'s EV-to-EBIT or its related term are showing as below:

JCOUF's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 18.68
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. The Jean Coutu Group (PJC)'s Enterprise Value for the quarter that ended in Nov. 2017 was $3,281 Mil. The Jean Coutu Group (PJC)'s EBIT for the trailing twelve months (TTM) ended in Nov. 2017 was $193 Mil. The Jean Coutu Group (PJC)'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2017 was 5.87%.


The Jean Coutu Group (PJC) EV-to-EBIT Historical Data

The historical data trend for The Jean Coutu Group (PJC)'s EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Jean Coutu Group (PJC) EV-to-EBIT Chart

The Jean Coutu Group (PJC) Annual Data
Trend May07 Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.33 7.51 16.36 15.82 12.75

The Jean Coutu Group (PJC) Quarterly Data
Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.16 12.75 14.50 14.62 16.98

Competitive Comparison of The Jean Coutu Group (PJC)'s EV-to-EBIT

For the Pharmaceutical Retailers subindustry, The Jean Coutu Group (PJC)'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Jean Coutu Group (PJC)'s EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Jean Coutu Group (PJC)'s EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Jean Coutu Group (PJC)'s EV-to-EBIT falls into.



The Jean Coutu Group (PJC) EV-to-EBIT Calculation

The Jean Coutu Group (PJC)'s EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3499.350/192.696
=18.16

The Jean Coutu Group (PJC)'s current Enterprise Value is $3,499 Mil.
The Jean Coutu Group (PJC)'s EBIT for the trailing twelve months (TTM) ended in Nov. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $193 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Jean Coutu Group (PJC)  (OTCPK:JCOUF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

The Jean Coutu Group (PJC)'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2017 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Nov. 2017 ) =EBIT / Enterprise Value (Q: Nov. 2017 )
=192.696/3280.98605
=5.87 %

The Jean Coutu Group (PJC)'s Enterprise Value for the quarter that ended in Nov. 2017 was $3,281 Mil.
The Jean Coutu Group (PJC)'s EBIT for the trailing twelve months (TTM) ended in Nov. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $193 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Jean Coutu Group (PJC) EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of The Jean Coutu Group (PJC)'s EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


The Jean Coutu Group (PJC) (The Jean Coutu Group (PJC)) Business Description

Traded in Other Exchanges
N/A
Address
The Jean Coutu Group is a Canadian pharmaceutical retailer that operates under a franchise model. The company reports three segments: franchising, generic medicines, and intersegment sales. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumes, discount cosmetic lines, photography services, household items, pet supplies, groceries, and personal-care products. The bulk of Jean Coutu's revenue comes from prescription drug sales.

The Jean Coutu Group (PJC) (The Jean Coutu Group (PJC)) Headlines

From GuruFocus

The Jean Coutu Group – Dividend Fourth Quarter of Fiscal Year 2018

By GlobeNewswire GlobeNewswire 04-01-2018